WallStreetZenWallStreetZen

NASDAQ: AVTX
Avalo Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for AVTX

Based on 2 analysts offering 12 month price targets for Avalo Therapeutics Inc.
Min Forecast
$3.00+3.81%
Avg Forecast
$6.00+107.61%
Max Forecast
$9.00+211.42%

Should I buy or sell AVTX stock?

Based on 2 analysts offering ratings for Avalo Therapeutics Inc.
Hold
Strong Buy
0 analysts 0%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
1 analysts 50%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AVTX stock forecasts and price targets.

AVTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
RBC Capital
Top 4%
97
BuyMaintains$9.00+211.42%2023-05-10
Jefferies
Top 7%
94
SellDowngrades$3.00+3.81%2023-02-08

1 of 1

Forecast return on equity

Is AVTX forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is AVTX forecast to generate an efficient return on assets?
Company
N/A
Industry
0.12%

AVTX revenue growth forecast

How is AVTX forecast to perform vs Biotechnology companies and vs the US market?
Company
16.71%
Industry
39.96%
Market
8.44%
AVTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AVTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AVTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AVTX$2.89$6.00+107.61%Hold
BCDA$1.89$9.00+376.19%Buy
CASI$2.85$10.00+250.88%Buy
NYMX$0.42N/AN/A
KALA$16.52$24.00+45.28%Buy
View Top Biotech Stocks

Avalo Therapeutics Stock Forecast FAQ

Is Avalo Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: AVTX) stock is to Hold AVTX stock.

Out of 2 analysts, 0 (0%) are recommending AVTX as a Strong Buy, 1 (50%) are recommending AVTX as a Buy, 0 (0%) are recommending AVTX as a Hold, 1 (50%) are recommending AVTX as a Sell, and 0 (0%) are recommending AVTX as a Strong Sell.

If you're new to stock investing, here's how to buy Avalo Therapeutics stock.

What is AVTX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: AVTX) forecast ROE is N/A, which is considered weak.

What is AVTX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year AVTX price target, the average AVTX price target is $6.00, with the highest AVTX stock price forecast at $9.00 and the lowest AVTX stock price forecast at $3.00.

On average, Wall Street analysts predict that Avalo Therapeutics's share price could reach $6.00 by May 10, 2024. The average Avalo Therapeutics stock price prediction forecasts a potential upside of 107.61% from the current AVTX share price of $2.89.

What is AVTX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: AVTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.